Thomas A. Bowden

11.0k total citations · 1 hit paper
90 papers, 4.5k citations indexed

About

Thomas A. Bowden is a scholar working on Infectious Diseases, Epidemiology and Molecular Biology. According to data from OpenAlex, Thomas A. Bowden has authored 90 papers receiving a total of 4.5k indexed citations (citations by other indexed papers that have themselves been cited), including 52 papers in Infectious Diseases, 38 papers in Epidemiology and 22 papers in Molecular Biology. Recurrent topics in Thomas A. Bowden's work include Viral Infections and Vectors (36 papers), Viral Infections and Outbreaks Research (29 papers) and Virology and Viral Diseases (21 papers). Thomas A. Bowden is often cited by papers focused on Viral Infections and Vectors (36 papers), Viral Infections and Outbreaks Research (29 papers) and Virology and Viral Diseases (21 papers). Thomas A. Bowden collaborates with scholars based in United Kingdom, United States and Finland. Thomas A. Bowden's co-authors include Max Crispin, Yasunori Watanabe, David I. Stuart, Ian A. Wilson, E. Yvonne Jones, Juha T. Huiskonen, Karl Harlos, David J. Harvey, Antra Zeltina and Marjorie Taylor and has published in prestigious journals such as Nature, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

Thomas A. Bowden

88 papers receiving 4.4k citations

Hit Papers

Exploitation of glycosylation in enveloped virus pathobio... 2019 2026 2021 2023 2019 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Thomas A. Bowden United Kingdom 38 2.6k 1.3k 1.2k 580 445 90 4.5k
Meng Yu Australia 39 4.1k 1.6× 2.0k 1.5× 781 0.6× 535 0.9× 808 1.8× 109 6.3k
Elizabeth E. Fry United Kingdom 41 1.9k 0.8× 851 0.6× 2.3k 1.9× 561 1.0× 207 0.5× 99 6.4k
Kartik Chandran United States 38 4.2k 1.6× 1.9k 1.4× 1.7k 1.4× 849 1.5× 850 1.9× 117 6.9k
Jean L. Patterson United States 40 2.2k 0.9× 1.3k 1.0× 1.0k 0.8× 274 0.5× 990 2.2× 115 4.4k
Stéphane Bressanelli France 29 1.3k 0.5× 1.5k 1.1× 1.1k 0.9× 314 0.5× 783 1.8× 71 3.9k
Elmars Grens Latvia 15 1.6k 0.6× 2.0k 1.5× 1.6k 1.3× 1.1k 1.9× 361 0.8× 18 5.2k
Ann C. Palmenberg United States 44 1.6k 0.6× 1.5k 1.1× 2.1k 1.7× 729 1.3× 492 1.1× 105 5.6k
Connie S. Schmaljohn United States 32 2.5k 1.0× 1.1k 0.9× 1.0k 0.9× 678 1.2× 564 1.3× 67 3.8k
Cristina Risco Spain 39 1.3k 0.5× 791 0.6× 1.2k 1.0× 537 0.9× 412 0.9× 88 4.0k
Anette Schneemann United States 37 995 0.4× 898 0.7× 1.3k 1.1× 648 1.1× 497 1.1× 66 4.0k

Countries citing papers authored by Thomas A. Bowden

Since Specialization
Citations

This map shows the geographic impact of Thomas A. Bowden's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas A. Bowden with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas A. Bowden more than expected).

Fields of papers citing papers by Thomas A. Bowden

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas A. Bowden. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas A. Bowden. The network helps show where Thomas A. Bowden may publish in the future.

Co-authorship network of co-authors of Thomas A. Bowden

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas A. Bowden. A scholar is included among the top collaborators of Thomas A. Bowden based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas A. Bowden. Thomas A. Bowden is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Rijal, Pramila, Guido C. Paesen, David I. Stuart, et al.. (2025). Structure-guided loop grafting improves expression and stability of influenza neuraminidase for vaccine development. eLife. 14. 1 indexed citations
3.
Sutton, Geoff, et al.. (2025). Molecular basis for occlusion of the jeilongvirus receptor-binding site by the elongated C-terminus. mBio. 17(1). e0150125–e0150125.
4.
Kim, Young Chan, Yasunori Watanabe, Xiyong Song, et al.. (2024). Immunogenic recombinant Mayaro virus-like particles present natively assembled glycoprotein. npj Vaccines. 9(1). 243–243. 3 indexed citations
5.
Oguntuyo, Kasopefoluwa Y., et al.. (2023). Crystal structure and solution state of the C-terminal head region of the narmovirus receptor binding protein. mBio. 14(5). e0139123–e0139123. 2 indexed citations
6.
Crowe, James E., et al.. (2023). Mechanistic basis for potent neutralization of Sin Nombre hantavirus by a human monoclonal antibody. Nature Microbiology. 8(7). 1293–1303. 9 indexed citations
7.
Escalera‐Zamudio, Marina, Sergei L. Kosakovsky Pond, Bernardo Gutiérrez, et al.. (2023). Identification of Evolutionary Trajectories Shared across Human Betacoronaviruses. Genome Biology and Evolution. 15(6). 1 indexed citations
8.
Grehan, Keith, Mark Hassall, Guido C. Paesen, et al.. (2023). VelcroVax: a “Bolt-On” Vaccine Platform for Glycoprotein Display. mSphere. 8(1). e0056822–e0056822. 3 indexed citations
9.
Hulswit, Ruben J. G., Jonna B. Westover, Guido C. Paesen, et al.. (2023). Multifunctional human monoclonal antibody combination mediates protection against Rift Valley fever virus at low doses. Nature Communications. 14(1). 5650–5650. 11 indexed citations
10.
Watanabe, Yasunori, Zachary T. Berndsen, Jayna Raghwani, et al.. (2020). Vulnerabilities in coronavirus glycan shields despite extensive glycosylation. Nature Communications. 11(1). 2688–2688. 240 indexed citations
11.
Rahikainen, Rolle, Pramila Rijal, Tiong Kit Tan, et al.. (2020). Overcoming Symmetry Mismatch in Vaccine Nanoassembly through Spontaneous Amidation. Angewandte Chemie International Edition. 60(1). 321–330. 63 indexed citations
12.
Rahikainen, Rolle, Pramila Rijal, Tiong Kit Tan, et al.. (2020). Overcoming Symmetry Mismatch in Vaccine Nanoassembly through Spontaneous Amidation. Angewandte Chemie. 133(1). 325–334. 9 indexed citations
13.
Nolan, Rory, et al.. (2018). A dynamic three-step mechanism drives the HIV-1 pre-fusion reaction. Nature Structural & Molecular Biology. 25(9). 814–822. 30 indexed citations
14.
Bowden, Thomas A., et al.. (2016). Immune recruitment or suppression by glycan engineering of endogenous and therapeutic antibodies. Biochimica et Biophysica Acta (BBA) - General Subjects. 1860(8). 1655–1668. 38 indexed citations
15.
Zhao, Yuguang, Jingshan Ren, Karl Harlos, et al.. (2016). Toremifene interacts with and destabilizes the Ebola virus glycoprotein. Nature. 535(7610). 169–172. 179 indexed citations
16.
Sommerstein, Rami, Lukas Flatz, Mélissa M. Remy, et al.. (2015). Arenavirus Glycan Shield Promotes Neutralizing Antibody Evasion and Protracted Infection. PLoS Pathogens. 11(11). e1005276–e1005276. 126 indexed citations
17.
Pernet, Olivier, Bradley S. Schneider, Shannon M. Beaty, et al.. (2014). Evidence for henipavirus spillover into human populations in Africa. Nature Communications. 5(1). 5342–5342. 142 indexed citations
18.
Bowden, Thomas A., A.R. Aricescu, Joanne E. Nettleship, et al.. (2009). Structural Plasticity of Eph-Receptor A4 Facilitates Cross-Class Ephrin Signaling (DOI:10.1016/j.str.2009.07.018). Structure. 17. 1679. 2 indexed citations
19.
Crispin, Max, Thomas A. Bowden, C.H. Coles, et al.. (2009). Carbohydrate and Domain Architecture of an Immature Antibody Glycoform Exhibiting Enhanced Effector Functions. Journal of Molecular Biology. 387(5). 1061–1066. 52 indexed citations
20.
Bowden, Thomas A., A.R. Aricescu, Robert J.C. Gilbert, et al.. (2008). Structural basis of Nipah and Hendra virus attachment to their cell-surface receptor ephrin-B2. Nature Structural & Molecular Biology. 15(6). 567–572. 184 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026